Astrana Health Inc. Reports Strong Q2 2025 Results

Astrana Health Inc. ( (ASTH) ) has released its Q2 earnings. Here is a breakdown of the information Astrana Health Inc. presented to its investors.

Astrana Health Inc. is a technology-driven healthcare company focused on providing high-quality, accessible care through its provider-centric model, operating primarily in the healthcare sector.

In its latest earnings report for the second quarter of 2025, Astrana Health Inc. reported strong financial results, with total revenue reaching $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of the company’s guidance. The company also successfully completed the acquisition of Prospect Health, which is expected to enhance its service offerings and market presence.

Key financial highlights include a 35% increase in total revenue compared to the same quarter last year, driven by a significant rise in Care Partners revenue. The company reported a net income of $9.4 million and an earnings per share of $0.19. For the first half of 2025, total revenue increased by 43% year-over-year, with net income attributable to Astrana reaching $16.1 million.

Strategic developments include the integration of Prospect Health’s assets and the appointment of new leadership roles to strengthen operational execution. The acquisition was financed through a term loan, and the company anticipates further growth through its expanded care delivery platform.

Looking ahead, Astrana Health maintains a positive outlook, reiterating its full-year guidance for 2025. The company remains committed to expanding access to coordinated care and leveraging its technology platform to drive sustainable growth and improved patient outcomes.